Clinical Guidelines
Compulsory drug detention centers in East and Southeast Asia
This article explores some of concerns created among the human rights community by the expansion of compulsory drug detention centres, including the lack of consent for treatment and due process protections for compulsory detention, the lack of general healthcare and evidence based drug dependency treatment.
This article explores some of concerns created among the human rights community by the expansion of compulsory drug detention centres, including the lack of consent for treatment and due process protections for compulsory detention, the lack of general healthcare and evidence based drug dependency treatment.
HIV, drugs and the legal environment
This article explores how public health and criminal justice professionals can work synergistically to shift the legal environment away from one that exacerbates HIV risks to one that promotes safe and healthy communities.
This article explores how public health and criminal justice professionals can work synergistically to shift the legal environment away from one that exacerbates HIV risks to one that promotes safe and healthy communities.
Prevention, treatment and care of hepatitis C virus infection among people who inject drugs
This paper analyses how restrictive law enforcement strategies are key drivers of the hepatitis C viral (HCV) epidemic among people who inject drugs and calls for enhanced HCV treatment settings.
This paper analyses how restrictive law enforcement strategies are key drivers of the hepatitis C viral (HCV) epidemic among people who inject drugs and calls for enhanced HCV treatment settings.
Prescription Drug Overdose in the United States
'Every day in the United States, 120 people die as a result of drug overdose'. This fact sheet from Centers for Disease Control and Prevention (CDC) reviews the problems and risk factors of prescription drug overdose.
'Every day in the United States, 120 people die as a result of drug overdose'. This fact sheet from Centers for Disease Control and Prevention (CDC) reviews the problems and risk factors of prescription drug overdose.
IDHDP side event
Thousands of people die unnecessarily from opioid overdose every year. This event will examine why the life saving drug naloxone is still unavailable and inaccessible to so many all over the world even after Members at the 55th CND unanimously endorsed a resolution promoting evidence-based strategies to address opioid overdose.
Thousands of people die unnecessarily from opioid overdose every year. This event will examine why the life saving drug naloxone is still unavailable and inaccessible to so many all over the world even after Members at the 55th CND unanimously endorsed a resolution promoting evidence-based strategies to address opioid overdose.
State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness
In 1981, when acquired immune deficiency syndrome (AIDS) was first observed among persons who inject drugs, almost all US states had laws criminalizing the possession and distribution of needles and syringes for injecting illicit drugs. We reviewed changes to these laws to permit ‘syringe exchanges’ and the provision of public funding for such programs.
In 1981, when acquired immune deficiency syndrome (AIDS) was first observed among persons who inject drugs, almost all US states had laws criminalizing the possession and distribution of needles and syringes for injecting illicit drugs. We reviewed changes to these laws to permit ‘syringe exchanges’ and the provision of public funding for such programs.
A public health approach to hepatitis C control in low and middle-income countries
An estimated 130–150 million people live with hepatitis C virus (HCV). A significant number of people with HCV will progress to chronic disease, hepatocellular carcinoma, and death. Approximately 80 million people live with chronic HCV infection, and in 2013 an estimated 700,000 people died from HCV. More than 80% of the HCV burden is in low and middle income countries.
An estimated 130–150 million people live with hepatitis C virus (HCV). A significant number of people with HCV will progress to chronic disease, hepatocellular carcinoma, and death. Approximately 80 million people live with chronic HCV infection, and in 2013 an estimated 700,000 people died from HCV. More than 80% of the HCV burden is in low and middle income countries.
People who inject drugs in prison: HIV prevalence, transmission and prevention
This article explores the transmission of HIV including outbreaks and the efforts to prevent transmission within the prison setting.
This article explores the transmission of HIV including outbreaks and the efforts to prevent transmission within the prison setting.
How should we measure addiction recovery?
‘Recovery’ has been an important concept in mental health services for nearly three decades (Scheyett, DeLuca, & Morgan, 2013) and is now an increasingly core feature of international addiction policy and practice.
‘Recovery’ has been an important concept in mental health services for nearly three decades (Scheyett, DeLuca, & Morgan, 2013) and is now an increasingly core feature of international addiction policy and practice.
